Heart news and heart widget

Over the past thirty years, there has been a significant decrease in risk of sudden cardiac death after myocardial infarction (heart attack), write researchers in the November 5 issue of JAMA. A. Selcuk Adabag, M.D., M.S. (Veterans Affairs Medical Center, Minneapolis) and colleagues at Mayo Clinic, Rochester, Minn.

When a patient ages, some heart valves, specifically the aortal valve, can begin to wear down. On Thursday, November 6th at 3 PM Eastern, join cardiac surgeons Alan Markowitz, MD, and Arie Blitz, MD, as they present a Freestyle Aortic Root Replacement. In addition to this viewers will also have the opportunity to see a replacement of ascending aorta and hemi-arch under circulatory arrest.

Pegasus/HeartVue LLC. (PINKSHEETS: PGUZ) today announced that they have now successfully completed the research and development for a new, non-invasive application of its patented HeartVue(TM) 6S System created specifically for Emergency Room environments.

For several years now, rimonabant (Acomplia, by Sanofi-Aventis) has been touted as the next pharmaceutical blockbuster. Several well-conducted clinical trials showed that rimonabant produced significant weight loss, aided in smoking...

Sanofi-aventis (NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the American Heart Journal published the rationale and design of the ongoing CURRENT-OASIS 7 trial, a study evaluating the effects of standard and higher-dosing regimens of Plavix® (clopidogrel bisulfate) and aspirin on cardiovascular outcomes and bleeding complications in patients with acute coronary syndrome (ACS) who are intended to undergo intervention with coronary angioplasty.

Title: Whole Grains Lower Risk of Heart FailureCategory: health newscreated: 11/6/2008 2:00:00 amlast Editorial review: 11/6/2008

Title: Lasting Damage From Fen-Phen Drug?Category: health newscreated: 11/6/2008Last Editorial review: 11/6/2008